SASE Architect

Information about the project:

• Industry: pharma

• Location: remote

• Contract: B2B

• Rate: we’re open to your suggestions

Introduction & Summary:

The SASE 2.0 Architect will be responsible for designing and documenting Client’s target state for SASE 2.0. The core deliverables include developing a SASE Discovery & Target State Strategy. The role demands a hands-on approach in architecting solutions and producing governance-quality documents aligned with ISO 27002:2022.

Main Responsibilities:

• Develop SASE Discovery & Target State Strategy document.

• Create a formal Bayer Security Standard with mapping to existing security frameworks.

• Draft Mini-SoW Task Orders for project approval.

• Produce detailed documentation adhering to Client’s BAFS framework.

• Map technology requirements to ISO 27002:2022 controls.

Key Requirements:

• Experience in designing full SASE architecture stack (end-to-end).

• Expertise in Secure Web Gateway (Zscaler ZIA, Netskope, etc.).

• Strong skills in Cloud Access Security Broker (CASB) integration.

• Knowledge of Zero Trust Network Access principles and platforms.

• Experience in Firewall-as-a-Service implementation and policy design.

• Proven ability to author concise, stakeholder-ready target state strategies.

• Formal experience in Security Standard (BSS) authoring aligned to governance frameworks.

• Hands-on mapping experience to ISO 27002:2022 controls.

• Ability to conduct structured gap analysis against countermeasure catalogues.

Nice to Have:

• Experience with hybrid network and SD-WAN integration.

• Prior authorship of reference architecture documents.

• Familiarity with proprietary security framework like BAFS.

• Knowledge in the pharma/life sciences sector.

• TOGAF or SABSA certification.

Other Details:

This role involves hands-on architecture and governance documentation in a rapidly evolving environment. The consultant will be expected to work autonomously and draft documents that adhere to strict security guidelines. Knowledge of regulatory environments is a plus, especially in the pharma sector.